FOR IMMEDIATE RELEASE: December 3, 2008, Medical Marketing Economics, LLC, is proud to announce the expansion and enhancement of its European pricing, reimbursement, and market access operations through the creation of MME Europe, in association with ValueVector S.r.l. MME, a leader in the development of value-based marketing, pricing and reimbursement strategies for pharmaceutical and biotechnology companies, was founded in 2001 and provides clients with value-based answers to their strategic marketing questions built upon first-hand experience and real-world thinking. By providing global solutions in the context of a practical ValueFrame™, MME assists clients in gaining rapid P&R approval and developing strategies to promote the uptake and use of new innovations. MME helps clients improve their profitability in the complex healthcare environment
Mick Kolassa, MME Chairman, has announced that the MME Europe management team will consist of Jack Mycka, Worldwide President and CEO, Renato Dellamano, President – Europe, and Tim Hammond, Vice President – Europe. This operation will be supported by professional personnel teams in the US and EU. Jack Mycka has been President of MME since 2004 and is spearheading the initiative to expand the value of MME provided strategies to global customers.
Since 2003, Dr. Dellamano has worked in close partnership with MME to support clients through ValueVector, his Milan, Italy, based strategic advisory agency. Dr. Dellamano is recognized as among the top worldwide experts in pharmaceutical pricing and reimbursement, with more than 20 years of direct extensive business experience. He was formerly the Global Head of Strategic Pricing at Hoffmann-La Roche, in Basel.
Mr. Hammond has over 25 years of experience in the fields of pharmaceutical marketing and pricing. Tim began his career as an economist in the Pricing and Reimbursement group for Glaxo, and through his careers has held senior positions with IMS Consulting, PharmaVentures Limited, and DataMonitor Healthcare Consulting.
MME Europe will be headquartered in Oxford, UK and will provide clients with comprehensive advice and services in:
- The development of pricing and reimbursement strategies and associated tactics, driven by our comprehensive experience and facilitated by the use of our proprietary methodologies including the Pricing Strategy Assessment® and ValueFrame Analysis®
- Creation and crafting of Core Value Dossiers to enhance local P&R negotiations
- Use of health economics to support the pricing and market access strategy
- Qualitative and quantitative pricing research with payers, providers, and patients in the US and European markets designed to provide market-wide insight
- Custom studies that encompass segmentation, positioning, target product profile development, and product tracking from a pricing/performance perspective
- Strategic guidance in the assessment and development of competitive strategies through our proprietary Competitive Engagement Simulation®
- Research and market understanding from multiple customers’ points of view to provide Total Marketspace AwarenessSM
- Pricing infrastructure evaluation, process, planning, and implementation
- P&R reality checks and due diligence for licensing activities
- Workshops and courses in all of these areas
For more information, please visit www.m2econ.com or e-mail us at info@m2econ.com. As always, MME is ready to help you:
Learn from our experience and profit from our thinking.SM
